• Search
  • Helpdesk
  • Sales contact

The benefits & practicalities of aligning the objectives of an eCOA vendor with those of the study

Last updated: June 24, 2024

Any enduring business relationship between a service provider and a client is built on a thorough understanding of the client’s needs, an atmosphere of mutual trust, and ultimately the satisfaction of all stakeholders.
For this to be achieved, contracts and Key Performance Indicators (KPIs) of Kayentis (a global eCOA provider) are developed in alignment with those of the client for each study. Below, Guillaume Juge (Kayentis CEO) highlights the company’s commitments to meet clients’ objectives:

aligning objectives ecoa vendor

Analyze the client’s needs and ensure the comprehensive understanding of the objectives of the study.

aligning objectives ecoa vendor

Assign a project manager with relevant experience of the therapeutic area and/or of any study-specific needs.

aligning objectives ecoa vendor

Build a sales policy, and especially a pricing policy, that allows the alignment of the objectives of Kayentis with those of the client. For example, the site/patient support, data management, and communication costs are defined up front for each study, meaning that Kayentis bears full responsibility for the efficiency of the underlying service and makes every effort to limit the number of queries. This provides full visibility to the client and helps to align objectives.

aligning objectives ecoa vendor

Define KPIs that are aligned with key study objectives. This includes timelines and compliance (the quantity and quality of data entry) as well as customer satisfaction (the Net Promoter Score is a robust “high level” indicator of customer satisfaction). Kayentis ensures that such KPIs are included in the remuneration policy.

aligning objectives ecoa vendor

Accept that a part of the invoicing should be variable! Alignment is made on the achievement of the study objectives or on other objectives that are considered to be relevant to the remuneration. For eCOA the level of patients’ compliance to eCOA tools (the quantity and quality of data entry) should be taken into account, as well as compliance with key study timelines and/or milestones.

To build long term partnerships with study sponsors and CROs, we are convinced that aligning our objectives with the study objectives is key”.

Guillaume JUGE, CEO – Kayentis

Follow us on social media
Subscribe to our newsletter
About the author
Meet us at the following events

The critical importance of Patient Reported Outcomes (PROs) for Emerging Biopharma Companies – Webinar

July 9 • 11-12AM EDT / 4-5PM GMT / 5-6PM CET
In today’s competitive landscape, biotech and emerging biopharma companies (EBPs) must demonstrate the value of their innovations early and convincingly....

DPHARM 2025

SEPT 16-17 2025 • Philadelphia, PA, USA
Booth #44 16th Annual Outsourcing in Clinical Trials East Coast 2025 - Arena International

SCDM 2025

Baltimore, Maryland, USA - 27-30 SEPT 2025
Annual Conference 2025 – SCDMLive    

SCOPE Europe 2025

OCT 14-15 2025 • Barcelona, Spain
SCOPE Europe | Summit for Clinical Operations Executives | October 14-15, 2025 |Barcelona, Spain